ophthalmic surgeon franklin nv and pediatric ophthalms dallas and san diegos eye doctors are working to develop a diagnostic tool that would help patients with an extremely rare type of eye disease to spot it early.
Ophthalmic surgery is the most common procedure in the US for people with age-related macular degeneration, or age-associated macular pigmentosum.
The condition causes a light-sensitive, thin film of cells in the retina that is usually seen on the outside of the eye.
It can cause blindness in the affected eye.
But many people are not aware of their condition, and the condition can be subtle, even if the light sensitivity and pigmentation are not visible, Dr Franklin McNamara of San Diego’s Mayo Clinic told News24.
“It’s not visible but the condition is a little bit hidden,” Dr McNamara said.
“And the only way to tell what’s going on is to look at the retina.”
For the first time, Dr McNara and his team are working on a new diagnostic tool to help patients who have early stage macular macular disease spot the eye disease.
The tool is called a bio-mechanical imaging system.
The system scans the retina for cells that can cause the macular disc to become transparent.
It uses laser light to do this.
The team has developed the tool so that the retina is scanned to scan the cells in order to detect whether there are signs of macular-eye disease.
“There’s something in the middle that’s sensitive to light,” Dr Franklin said.
“If you put that right on the retina, you’ll see it.”
It scans the retinal tissue, and a computer generates a digital image of the tissue in the form of a dot pattern.
The image can then be examined by using a 3D computer vision system.
“This will be a digital computer image of your retina,” Dr Nesbitt said.
Dr McNamara, a member of the Mayo Clinic’s Eye and Vision Center, is also a member and CEO of the American Ophthalmological Society, and he has a PhD in ophthalmology from the University of California, Los Angeles.
The eye doctor said that the eye health care system needs to catch up.
“We have to make sure we get the right technologies for the right people,” Dr Frank said.
For now, the team is focusing on developing a device that can detect early stage Macular Macular pigmentosa.
Dr Franklin said it’s a new type of diagnostic tool and that its discovery could be used to identify people with early stage disease.
Ophthalmologists will need to be trained in how to interpret the technology and understand the clinical implications.
Dr Nesbritt said it could also be used in a surgical setting to see how long a patient is going to be able to tolerate wearing a glasses, and to see whether the glasses are safe.
The research was published in the journal Ophthalmology.